| 2025年中报 | 2024年年报 | 2024年中报 | |
|---|---|---|---|
| 营业收入(元) | |||
| 技术服务(元) | 20,591,361.31 | 63,489,780.31 | 40,889,246.81 |
| 药品销售(元) | 42,202,201.99 | 92,171,983.00 | 44,099,882.68 |
| 营业成本(元) | |||
| 技术服务(元) | 3,634,230.03 | 6,594,556.61 | 3,285,995.21 |
| 药品销售(元) | 29,569,002.21 | 63,252,856.79 | 30,283,017.69 |
| 毛利(元) | |||
| 技术服务(元) | 16,957,131.28 | 56,895,223.70 | 37,603,251.60 |
| 药品销售(元) | 12,633,199.78 | 28,919,126.21 | 13,816,864.99 |
| 毛利率(%) | |||
| 技术服务(%) | 82.35 | 89.61 | 91.96 |
| 药品销售(%) | 29.93 | 31.38 | 31.33 |
| 收入构成(%) | |||
| 技术服务(%) | 32.79 | 40.79 | 48.11 |
| 药品销售(%) | 67.21 | 59.21 | 51.89 |
| 毛利构成(%) | |||
| 技术服务(%) | 57.31 | 66.30 | 73.13 |
| 药品销售(%) | 42.69 | 33.70 | 26.87 |
